Real-world use of emapalumab in hemophagocytic lymphohistiocytosis: a scoping review of published evidence.
Saved in:
| Title: | Real-world use of emapalumab in hemophagocytic lymphohistiocytosis: a scoping review of published evidence. |
|---|---|
| Authors: | Al-Mashdali AF; Department of Hematology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Mohamed F; Department of Public and Environmental Health, Faculty of Medicine, Gezira University, Wad Madani, Sudan., Osman M; Faculty of Medicine, Shendi University, Shendi, Sudan., Abdelraof MO; Department of Public and Environmental Health, Faculty of Medicine, Gezira University, Wad Madani, Sudan., Al Rasheed M; Clinical Hematology Department, Adan Hospital, Al Ahmadi, Kuwait., Salama H; Adult Hematology Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia., Mohamed SF; Department of Hematology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Yassin MA; Department of Hematology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2026 Apr 10; Vol. 17, pp. 1749084. Date of Electronic Publication: 2026 Apr 10 (Print Publication: 2026). |
| Publication Type: | Journal Article; Systematic Review |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2026.1749084 |
